Stuvia.com - The Marketplace to Buy and Sell your Study Material .d .d .d .d .d .d .d .d .d .d
Chapter1:IndicationsforPulmonaryFunctionTesting Test
.d .d .d .d .d .d .d
Bank
.d
MULTIPLE CHOICE .d
1. Who first popularized spirometry for the evaluation of pulmonary function?
.d .d .d .d .d .d .d .d .d
a. August and Marie Krogh .d .d .d
b. Alvan Barach .d
c. John Severinghaus .d
d. John Hutchinson .d
ANS: D . d . d
Hutchinson popularized the concept of using VC to assess lung function, and the nameshe gave to .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
several other lung compartments are still used today.
.d .d .d .d .d .d .d .d
DIF: 1 REF: p. 2 .d OBJ: None MSC: NBRC: None . d .d
2. Whichof the following are indications for performing spirometry?
.d .d .d .d .d .d .d .d
1. Assess the risk of lung resection. .d .d .d .d .d
2. Determine the response to bronchodilator therapy. .d .d .d .d .d
3. Assess the severity of restrictive lung disease. .d .d .d .d .d .d
4. Quantify the extent of COPD. .d .d .d .d
a. 1 and 4 .d .d
b. 2 and 3 .d .d
c. 1, 2, and 4 .d .d .d
d. 2, 3, and 4 .d .d .d
ANS: C . d . d
Spirometry cannot assess severityof restriction; for that you need to measurelung volumes (see Box .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
1-2, Chapter 1).
.d .d .d
DIF: 1 REF: p. 7 .d OBJ: EL-2 MSC: NBRC: None . d .d
3. The main indication for the measurement of lung volumes is to do which of the following?
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
a. Diagnose or assess the severity of restriction. .d .d .d .d .d .d
b. Evaluate the severity of pulmonary hypertension. .d .d .d .d .d
c. Determine the level of cardiopulmonary fitness. .d .d .d .d .d
d. Assess the risk of abdominal surgical procedures. .d .d .d .d .d .d
ANS: A . d . d
The most common reason for measuring lung volumesis to identify restrictive lung disease. DIF:
.d .d .d .d .d .d .d .d .d .d .d .d .d .d
1 REF: p. 35 .d OBJ: EL-2 MSC: . d NBRC: None .d
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of the
.d .d .d .d .d .d .d .d .d .d .d .d
following systemic diseases?
.d .d .d
a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia .d
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
, Stuvia.com - The Marketplace to Buy and Sell your Study Material .d .d .d .d .d .d .d .d .d .d
d. Guillain-Barré syndrome .d
ANS: B . d . d
Sarcoidosisis the only systemic disease listed that affects gas exchange. .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 .d .d .d .d .d .d .d .d .d .d OBJ: EL-2
MSC: NBRC: None
.d . d .d
5. Blood gas analysis is used with patients with COPD to do which of the following?
.d .d .d .d .d .d .d .d .d .d .d .d .d .d
a. Monitor airway responsiveness. .d .d
b. Determine level of cardiopulmonary fitness. .d .d .d .d
c. Detect pulmonary hypertension. .d .d
d. Assess need for supplementary O2. .d .d .d .d
ANS: D . d . d
Blood gas analysis is most commonly used to determine the need for supplemental oxygen and to
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
manage patients who require ventilatory support.
.d .d .d .d .d .d
DIF: 2 REF: p. 15 .d OBJ: EL-1
MSC: NBRC: CPFT 2A-2
.d . d .d .d
6. Which of the following cause emphysema?
.d .d .d .d .d
1. 1-Antitrypsin deficiency .d
2. Exposure to environmental pollutants .d .d .d
3. Radiation therapy .d
4. Cigarette smoking .d
a. 1 and 2 .d .d
b. 3 and 4 .d .d
c. 1, 2, and 4 .d .d .d
d. 2, 3, and 4 .d .d .d
ANS: C . d . d
Emphysema is caused primarily bycigarette smoking. Some emphysema is caused by the absence of .d .d .d .d .d .d .d .d .d .d .d .d .d .d
a protective enzyme. Chronic exposure to environmental pollutants can also contribute to the
.d .d .d .d .d .d .d .d .d .d .d .d .d
development of emphysema.
.d .d .d
DIF: 1 REF: p. 11 .d OBJ: EL-3 | AL-2 .d .d MSC: NBRC: None . d .d
7. An adult patient complainsof chest tightness and cough whenever he jogs in cold weather. These
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
symptoms are consistent with which of the following?
.d .d .d .d .d .d .d .d
a. Cystic fibrosis .d
b. Asthma
c. Pulmonary hypertension .d
d. Idiopathic pulmonary fibrosis .d .d
ANS: B . d . d
Agents or events that cause an asthmatic episode are called triggers (see Box 1-7, Chapter 1).
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
Antigens such as animal dander, pollens, and dustsare the mostcommon triggers. Other common
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
triggers include exposure to air pollutants and exercise in cold or dry air.
.d .d .d .d .d .d .d .d .d .d .d .d .d
DIF: 2 REF: p. 16 .d OBJ: EL-3 MSC: NBRC: None . d .d
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
, Stuvia.com - The Marketplace to Buy and Sell your Study Material .d .d .d .d .d .d .d .d .d .d
8. Whichof the following statements concerning tumors in the upper airway is true?
.d .d .d .d .d .d .d .d .d .d .d .d
a. There may be variable or fixed obstruction. .d .d .d .d .d .d
b. Fixed obstruction will be present. .d .d .d .d
c. Variable obstruction will be present. .d .d .d .d
d. Small airway obstruction will result. .d .d .d .d
ANS: A . d . d
Tumors involving the upper airway may cause variable or fixed obstruction.
.d .d .d .d .d .d .d .d .d .d
DIF: 2 REF: p. 19 .d OBJ: EL-2
MSC: NBRC: CPFT 3C-3
.d . d .d .d
9. Sarcoidosis is a systemic disorder that usually causes which of the following? .d .d .d .d .d .d .d .d .d .d .d
a. A restrictive ventilatory defect
.d .d .d
b. An obstructive ventilatory defect .d .d .d
c. Hyperreactive airways .d
d. Primary pulmonary hypertension .d .d
ANS: A . d . d
Restrictionis often associated with thefollowing: interstitiallungdiseases, including idiopathic .d .d .d .d .d .d .d .d .d .d .d
fibrosis, pneumoconioses, and sarcoidosis.
.d .d .d .d
DIF: 1 REF: p. 19 | p. 21 .d .d .d .d OBJ: EL-3 MSC: NBRC: None . d .d
10. Forwhich of the following conditions might pulmonary function testing be contraindicated?
.d .d .d .d .d .d .d .d .d .d .d
a. Vocal cord dysfunction .d .d
b. Untreated pneumothorax .d
c. Congestive heart failure (CHF) .d .d .d
d. Bronchiolitis obliterans .d
ANS: B . d . d
Pulmonary function tests are usually contraindicated in the presence of pneumothorax. However, .d .d .d .d .d .d .d .d .d .d .d
undiagnosed pneumothorax maypresent a risk if pulmonaryfunction studiesare performed.
.d .d .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 23 .d OBJ: EL-4
MSC: NBRC: CPFT 2B-6
.d . d .d .d
11. Whichof thefollowing correctlydescribe(s)appropriate physical measurementsbefore
.d .d .d .d .d .d .d .d .d
pulmonary function testing?
.d .d .d
1. Actual body weight should be used to calculate predicted values. .d .d .d .d .d .d .d .d .d
2. Standing height should be measured when the patient is barefoot. .d .d .d .d .d .d .d .d .d
3. Arm span should be used instead of height for a patient with kyphosis. .d .d .d .d .d .d .d .d .d .d .d .d
4. Age should be recorded to the nearest decade (10 years). .d .d .d .d .d .d .d .d .d
a. 1 only .d
b. 2 and 3 .d .d
c. 1, 2, and 4 .d .d .d
d. 1,2,3,and4 .d .d .d .d
.d ANS: . d B
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
, Stuvia.com - The Marketplace to Buy and Sell your Study Material .d .d .d .d .d .d .d .d .d .d
Variousphysical measurements are required for estimating each patient’s expected level of
.d .d .d .d .d .d .d .d .d .d .d
pulmonary function. Age to the nearest month, height to the nearest 0.1 cm, and weight are usually
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
recorded in addition to the patient’s gender. Race or ethnic origin should also be recorded.
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
(Although body weight is recorded, it is not used to calculate predicted values.)
.d .d .d .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 29 .d OBJ: None
MSC: NBRC: CPFT 3A-20
.d . d .d .d
12. In addition to explaining the procedure for each pulmonary function test to the patient, the
.d .d .d .d .d .d .d .d .d .d .d .d .d .d
pulmonary function technologist should do which of the following?
.d .d .d .d .d .d .d .d .d
a. Briefly explain the physiologic basis of the test. .d .d .d .d .d .d .d
b. Demonstratethe correct performance of the test maneuver. .d .d .d .d .d .d .d
c. Limit feedback to the patient to reduce the placebo effect.
.d .d .d .d .d .d .d .d .d
d. Explain the exact number of efforts that will be required for each test. .d .d .d .d .d .d .d .d .d .d .d .d
ANS: B . d . d
In addition to a description of the test, the maneuver should always be demonstrated.
.d .d .d .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 32 .d OBJ: None
MSC: NBRC: CPFT 2B-6
.d . d .d .d
13. The single-breath diffusing capacity test was first described by:
.d .d .d .d .d .d .d .d
a. John Severinghaus .d
b. August and Marie Krogh .d .d .d
c. Robert Hyatt .d
d. Leland Clark .d
ANS: B . d . d
The basis for the modern single-breath diffusing capacity (DLCO) test was described by August
.d .d .d .d .d .d .d .d .d .d .d .d .d
and Marie Krogh in 1911.
.d .d .d .d .d
DIF: 1 REF: p. 5 .d OBJ: None MSC: NBRC: None . d .d
14. DLCO measurements may be indicated to evaluate gas exchange abnormalityin which of the
.d .d .d .d .d .d .d .d .d .d .d .d .d
following?
.d
a. Ketoacidosis
b. Myasthenia gravis .d
c. Interstitial lung disease .d .d
d. Bronchitis
ANS: C . d . d
The other options do not affect the alveolar capillary membrane interface.
.d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 9 .d OBJ: EL-2 MSC: NBRC: None . d .d
15. Vocal cord dysfunction will typically affect the flow-volume loop in what way?
.d .d .d .d .d .d .d .d .d .d .d
a. Blunt the expiratory portion of the curve .d .d .d .d .d .d
b. Blunt both the inspiratory and expiratory portions of the curve
.d .d .d .d .d .d .d .d .d
c. Blunt the inspiratory portion of the curve .d .d .d .d .d .d
d. Have no effect on the curve but cause inspiratory stridor
.d .d .d .d .d .d .d .d .d
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
Chapter1:IndicationsforPulmonaryFunctionTesting Test
.d .d .d .d .d .d .d
Bank
.d
MULTIPLE CHOICE .d
1. Who first popularized spirometry for the evaluation of pulmonary function?
.d .d .d .d .d .d .d .d .d
a. August and Marie Krogh .d .d .d
b. Alvan Barach .d
c. John Severinghaus .d
d. John Hutchinson .d
ANS: D . d . d
Hutchinson popularized the concept of using VC to assess lung function, and the nameshe gave to .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
several other lung compartments are still used today.
.d .d .d .d .d .d .d .d
DIF: 1 REF: p. 2 .d OBJ: None MSC: NBRC: None . d .d
2. Whichof the following are indications for performing spirometry?
.d .d .d .d .d .d .d .d
1. Assess the risk of lung resection. .d .d .d .d .d
2. Determine the response to bronchodilator therapy. .d .d .d .d .d
3. Assess the severity of restrictive lung disease. .d .d .d .d .d .d
4. Quantify the extent of COPD. .d .d .d .d
a. 1 and 4 .d .d
b. 2 and 3 .d .d
c. 1, 2, and 4 .d .d .d
d. 2, 3, and 4 .d .d .d
ANS: C . d . d
Spirometry cannot assess severityof restriction; for that you need to measurelung volumes (see Box .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
1-2, Chapter 1).
.d .d .d
DIF: 1 REF: p. 7 .d OBJ: EL-2 MSC: NBRC: None . d .d
3. The main indication for the measurement of lung volumes is to do which of the following?
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
a. Diagnose or assess the severity of restriction. .d .d .d .d .d .d
b. Evaluate the severity of pulmonary hypertension. .d .d .d .d .d
c. Determine the level of cardiopulmonary fitness. .d .d .d .d .d
d. Assess the risk of abdominal surgical procedures. .d .d .d .d .d .d
ANS: A . d . d
The most common reason for measuring lung volumesis to identify restrictive lung disease. DIF:
.d .d .d .d .d .d .d .d .d .d .d .d .d .d
1 REF: p. 35 .d OBJ: EL-2 MSC: . d NBRC: None .d
4. DLCO measurements may be indicated to evaluate pulmonary involvement in which of the
.d .d .d .d .d .d .d .d .d .d .d .d
following systemic diseases?
.d .d .d
a. Asthma
b. Sarcoidosis
c. Exertional hypoxemia .d
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
, Stuvia.com - The Marketplace to Buy and Sell your Study Material .d .d .d .d .d .d .d .d .d .d
d. Guillain-Barré syndrome .d
ANS: B . d . d
Sarcoidosisis the only systemic disease listed that affects gas exchange. .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 9 | p. 19 | p. 21 | p. 35 .d .d .d .d .d .d .d .d .d .d OBJ: EL-2
MSC: NBRC: None
.d . d .d
5. Blood gas analysis is used with patients with COPD to do which of the following?
.d .d .d .d .d .d .d .d .d .d .d .d .d .d
a. Monitor airway responsiveness. .d .d
b. Determine level of cardiopulmonary fitness. .d .d .d .d
c. Detect pulmonary hypertension. .d .d
d. Assess need for supplementary O2. .d .d .d .d
ANS: D . d . d
Blood gas analysis is most commonly used to determine the need for supplemental oxygen and to
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
manage patients who require ventilatory support.
.d .d .d .d .d .d
DIF: 2 REF: p. 15 .d OBJ: EL-1
MSC: NBRC: CPFT 2A-2
.d . d .d .d
6. Which of the following cause emphysema?
.d .d .d .d .d
1. 1-Antitrypsin deficiency .d
2. Exposure to environmental pollutants .d .d .d
3. Radiation therapy .d
4. Cigarette smoking .d
a. 1 and 2 .d .d
b. 3 and 4 .d .d
c. 1, 2, and 4 .d .d .d
d. 2, 3, and 4 .d .d .d
ANS: C . d . d
Emphysema is caused primarily bycigarette smoking. Some emphysema is caused by the absence of .d .d .d .d .d .d .d .d .d .d .d .d .d .d
a protective enzyme. Chronic exposure to environmental pollutants can also contribute to the
.d .d .d .d .d .d .d .d .d .d .d .d .d
development of emphysema.
.d .d .d
DIF: 1 REF: p. 11 .d OBJ: EL-3 | AL-2 .d .d MSC: NBRC: None . d .d
7. An adult patient complainsof chest tightness and cough whenever he jogs in cold weather. These
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
symptoms are consistent with which of the following?
.d .d .d .d .d .d .d .d
a. Cystic fibrosis .d
b. Asthma
c. Pulmonary hypertension .d
d. Idiopathic pulmonary fibrosis .d .d
ANS: B . d . d
Agents or events that cause an asthmatic episode are called triggers (see Box 1-7, Chapter 1).
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
Antigens such as animal dander, pollens, and dustsare the mostcommon triggers. Other common
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
triggers include exposure to air pollutants and exercise in cold or dry air.
.d .d .d .d .d .d .d .d .d .d .d .d .d
DIF: 2 REF: p. 16 .d OBJ: EL-3 MSC: NBRC: None . d .d
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
, Stuvia.com - The Marketplace to Buy and Sell your Study Material .d .d .d .d .d .d .d .d .d .d
8. Whichof the following statements concerning tumors in the upper airway is true?
.d .d .d .d .d .d .d .d .d .d .d .d
a. There may be variable or fixed obstruction. .d .d .d .d .d .d
b. Fixed obstruction will be present. .d .d .d .d
c. Variable obstruction will be present. .d .d .d .d
d. Small airway obstruction will result. .d .d .d .d
ANS: A . d . d
Tumors involving the upper airway may cause variable or fixed obstruction.
.d .d .d .d .d .d .d .d .d .d
DIF: 2 REF: p. 19 .d OBJ: EL-2
MSC: NBRC: CPFT 3C-3
.d . d .d .d
9. Sarcoidosis is a systemic disorder that usually causes which of the following? .d .d .d .d .d .d .d .d .d .d .d
a. A restrictive ventilatory defect
.d .d .d
b. An obstructive ventilatory defect .d .d .d
c. Hyperreactive airways .d
d. Primary pulmonary hypertension .d .d
ANS: A . d . d
Restrictionis often associated with thefollowing: interstitiallungdiseases, including idiopathic .d .d .d .d .d .d .d .d .d .d .d
fibrosis, pneumoconioses, and sarcoidosis.
.d .d .d .d
DIF: 1 REF: p. 19 | p. 21 .d .d .d .d OBJ: EL-3 MSC: NBRC: None . d .d
10. Forwhich of the following conditions might pulmonary function testing be contraindicated?
.d .d .d .d .d .d .d .d .d .d .d
a. Vocal cord dysfunction .d .d
b. Untreated pneumothorax .d
c. Congestive heart failure (CHF) .d .d .d
d. Bronchiolitis obliterans .d
ANS: B . d . d
Pulmonary function tests are usually contraindicated in the presence of pneumothorax. However, .d .d .d .d .d .d .d .d .d .d .d
undiagnosed pneumothorax maypresent a risk if pulmonaryfunction studiesare performed.
.d .d .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 23 .d OBJ: EL-4
MSC: NBRC: CPFT 2B-6
.d . d .d .d
11. Whichof thefollowing correctlydescribe(s)appropriate physical measurementsbefore
.d .d .d .d .d .d .d .d .d
pulmonary function testing?
.d .d .d
1. Actual body weight should be used to calculate predicted values. .d .d .d .d .d .d .d .d .d
2. Standing height should be measured when the patient is barefoot. .d .d .d .d .d .d .d .d .d
3. Arm span should be used instead of height for a patient with kyphosis. .d .d .d .d .d .d .d .d .d .d .d .d
4. Age should be recorded to the nearest decade (10 years). .d .d .d .d .d .d .d .d .d
a. 1 only .d
b. 2 and 3 .d .d
c. 1, 2, and 4 .d .d .d
d. 1,2,3,and4 .d .d .d .d
.d ANS: . d B
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
, Stuvia.com - The Marketplace to Buy and Sell your Study Material .d .d .d .d .d .d .d .d .d .d
Variousphysical measurements are required for estimating each patient’s expected level of
.d .d .d .d .d .d .d .d .d .d .d
pulmonary function. Age to the nearest month, height to the nearest 0.1 cm, and weight are usually
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
recorded in addition to the patient’s gender. Race or ethnic origin should also be recorded.
.d .d .d .d .d .d .d .d .d .d .d .d .d .d .d
(Although body weight is recorded, it is not used to calculate predicted values.)
.d .d .d .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 29 .d OBJ: None
MSC: NBRC: CPFT 3A-20
.d . d .d .d
12. In addition to explaining the procedure for each pulmonary function test to the patient, the
.d .d .d .d .d .d .d .d .d .d .d .d .d .d
pulmonary function technologist should do which of the following?
.d .d .d .d .d .d .d .d .d
a. Briefly explain the physiologic basis of the test. .d .d .d .d .d .d .d
b. Demonstratethe correct performance of the test maneuver. .d .d .d .d .d .d .d
c. Limit feedback to the patient to reduce the placebo effect.
.d .d .d .d .d .d .d .d .d
d. Explain the exact number of efforts that will be required for each test. .d .d .d .d .d .d .d .d .d .d .d .d
ANS: B . d . d
In addition to a description of the test, the maneuver should always be demonstrated.
.d .d .d .d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 32 .d OBJ: None
MSC: NBRC: CPFT 2B-6
.d . d .d .d
13. The single-breath diffusing capacity test was first described by:
.d .d .d .d .d .d .d .d
a. John Severinghaus .d
b. August and Marie Krogh .d .d .d
c. Robert Hyatt .d
d. Leland Clark .d
ANS: B . d . d
The basis for the modern single-breath diffusing capacity (DLCO) test was described by August
.d .d .d .d .d .d .d .d .d .d .d .d .d
and Marie Krogh in 1911.
.d .d .d .d .d
DIF: 1 REF: p. 5 .d OBJ: None MSC: NBRC: None . d .d
14. DLCO measurements may be indicated to evaluate gas exchange abnormalityin which of the
.d .d .d .d .d .d .d .d .d .d .d .d .d
following?
.d
a. Ketoacidosis
b. Myasthenia gravis .d
c. Interstitial lung disease .d .d
d. Bronchitis
ANS: C . d . d
The other options do not affect the alveolar capillary membrane interface.
.d .d .d .d .d .d .d .d .d .d
DIF: 1 REF: p. 9 .d OBJ: EL-2 MSC: NBRC: None . d .d
15. Vocal cord dysfunction will typically affect the flow-volume loop in what way?
.d .d .d .d .d .d .d .d .d .d .d
a. Blunt the expiratory portion of the curve .d .d .d .d .d .d
b. Blunt both the inspiratory and expiratory portions of the curve
.d .d .d .d .d .d .d .d .d
c. Blunt the inspiratory portion of the curve .d .d .d .d .d .d
d. Have no effect on the curve but cause inspiratory stridor
.d .d .d .d .d .d .d .d .d
DD
oDw
oow
nwlno
nla
loodaaedddedbybb:yS
:u
kAipsre
iharehA|||paaabbpbiieigeklciatlcyinh1@
@
2@
ggm
m
gm
aaiilal..ciclo
.ocm
om .d
Distribution of this document is illegal .d .d .d .d .d
